I'm LongbridgeAI, I can summarize articles.Synopsys (SNPS) fell 3.12% for the week to close at $384.97, underperforming the S&P 500, which slipped just 0.08%. The stock swung 8.24% over the five sessions, a much wider range than normal. It opened Monday at $393.89, then slid through the week, hitting a 52-week low of $362.55 intraday on Tuesday, 15 September. The next three sessions saw a gradual rebound, with Friday’s close at $384.97 still below the prior week’s $397.38 finish.
The Week
Synopsys (SNPS) fell 3.12% for the week to close at $384.97, underperforming the S&P 500, which slipped just 0.08%. The stock swung 8.24% over the five sessions, a much wider range than normal. It opened Monday at $393.89, then slid through the week, hitting a 52-week low of $362.55 intraday on Tuesday, 15 September. The next three sessions saw a gradual rebound, with Friday’s close at $384.97 still below the prior week’s $397.38 finish. The share price now sits beneath both the 20-day moving average at $403.64 and the 60-day at $409.32, leaving the near-term trend on the soft side.
Key Events
Two forces dominated the company-specific news flow this week: insider selling and quantum-computing collaboration. On 16 September, reports emerged that the company’s chairman had sold roughly $32 million worth of shares, the same day the stock touched its 52-week low of $362.55. On 17 September, CEO Ghazi Sassine disclosed the disposal of 14,604 common shares worth $5.47 million. Countering that, IonQ and Synopsys announced an integration of a quantum algorithm into ANSYS’s LS-DYNA simulations, cutting runtime by up to 14.6%. The announcement lifted sentiment around the names involved in Thursday’s after-hours trade. Overall, the week tilted toward insider disposals, and the quantum tie-up has yet to stabilise the share price.
Analyst Ratings
Among 27 institutions covering the name, 17 rate it buy and 5 rate it overweight, for a combined 22 buy or overweight ratings; 2 are at hold, 1 at underweight, and 2 have no opinion. The consensus rating is strong buy, with a consensus target of $545.93, about 41.81% above the current price of $384.97. Targets range from a low of $414.77 to a high of $633.00, a wide spread that points to meaningful disagreement. Within the application-software industry, Synopsys ranks 15th out of 191 companies, putting it in the top 8%.
The Week Ahead
Macro data dominates next week’s calendar. The Richmond Fed composite index lands on Tuesday, 22 September, with a prior of 4. Wednesday, 23 September, brings the EIA crude and Cushing inventory reports. Thursday, 24 September, is the busiest: initial jobless claims, the current-account deficit, new-home sales at an annualised rate, and natural-gas storage changes. There are no Synopsys-specific earnings or corporate events on the calendar. The focus will be on whether the macro prints shift risk appetite for software names and whether the post-disclosure flows in SNPS change direction.
In Short
Synopsys sits at an interesting junction. Broker sentiment remains firmly positive, with a strong-buy consensus and a target roughly 42% above spot, and the stock sits in the top 8% of its industry by rating. At the same time, the chairman and CEO both disclosed share sales this week, the price broke below key moving averages, and it underperformed the broader market by about three percentage points. On valuation, the stock trades around 68.5 times earnings, while the latest session’s large-lot flow showed net buying. The question ahead is whether the quantum-collaboration momentum can convert into orders and how macro-driven flows affect the software complex.
This article is generated by LongbridgeAI from market data, for information only and not investment advice.